Beispiel: Heart Attack

Klinische Studien zur Polyradiculoneuropathie, chronisch entzündliche Demyelinisierung

Insgesamt 67 ergebnisse

NCT04742374

Noch nicht rekrutiert

Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Bedingungen: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT01017159

Abgeschlossen

Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Bedingungen: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT01625182

Abgeschlossen

Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

Bedingungen: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04051944

Anmeldung auf Einladung

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Bedingungen: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT04529291

Noch nicht rekrutiert

InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Bedingungen: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT03861481

Aktiv, nicht rekrutierend

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Bedingungen: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT00220740

Abgeschlossen

Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Bedingungen: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT03967899

Aktiv, nicht rekrutierend

Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Bedingungen: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT02027701

Abgeschlossen

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT02271724

Unbekannter Status

sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN

Bedingungen: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT00305266

Abgeschlossen

Study of CIDP Patients During IVIG Treatment

Bedingungen: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT00099489

Abgeschlossen

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Bedingungen: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT01824251

Abgeschlossen

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy
NCT04658472

Rekrutierung

Proof-of-concept Study for BIVV020 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Bedingungen: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04480450

Noch nicht rekrutiert

Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy: A Phase II Study

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy
NCT01379833

Abgeschlossen

Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy
NCT01184846

Abgeschlossen

Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy
NCT00004772

Abgeschlossen

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy

Bedingungen: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT03772717

Noch nicht rekrutiert

Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy
NCT01236456

Zurückgezogen

High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy
NCT04281472

Rekrutierung

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT04280718

Rekrutierung

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT00278629

Abgeschlossen

Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy

Bedingungen: Chronic Inflammatory Demyelinating Polyneuropathy
NCT03008733

Rekrutierung

Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG

Bedingungen: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT02892890

Unbekannter Status

Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin

Bedingungen: Chronic Inflammatory Demyelinating Polyradiculoneuropathy